Fortress Biotech Inc Pref Series A (FBIOP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $14.36
• Market Cap: $73.33M
• EPS: $-0.86
• 52-Week High: $13.84
• 52-Week Low: $4.72

Market Sentiment

Fortress Biotech Inc Pref Series A currently has a Neutral sentiment score of 0.07.

About Fortress Biotech Inc Pref Series A

Fortress Biotech Inc. (FBIOP) is a New York-based biopharmaceutical company dedicated to the development and commercialization of cutting-edge pharmaceutical and biotech products. The company leverages innovative drug development platforms to improve patient care, with a diverse pipeline addressing various therapeutic areas. Fortress's strategic focus on advancing healthcare solutions not only underscores its commitment to enhancing treatment options but also positions it as an attractive inv...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Fortress Biotech Inc Pref Series A and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does FBIOP pay dividends?

Fortress Biotech Inc Pref Series A (FBIOP) does not currently pay a regular dividend.

What is FBIOP's market cap?

Fortress Biotech Inc Pref Series A (FBIOP) has a market capitalization of $73.33M with a current stock price of $14.36.